ZEAL:CPH
Zealand Pharma A/S
DKK 238,00
arrow_upward
+0,42%(+1,00) 1 HR
9 Okt, 17.00.00 GMT+2 · DKK
search
Semua simbol
| Simbol | Harga | Perubahan | Persentase Perubahan |
|---|
insights_autoMembuat insight teratas untuk ZEAL...
Pembukaan
DKK 240,00
Tinggi
DKK 241,70
Rendah
DKK 236,00
Kapitalisasi pasar
17,04 M
Volume rata-rata
412,72 rb
Volume
293,77 rb
Harga tinggi dalam 52 minggu terakhir
DKK 556,00
Harga rendah dalam 52 minggu terakhir
DKK 233,50
Saham beredar
71,61 jt
Jumlah karyawan
578
Pembukaan
DKK 240,00
Tinggi
DKK 241,70
Rendah
DKK 236,00
Kapitalisasi pasar
17,04 M
Volume rata-rata
412,72 rb
Volume
293,77 rb
Harga tinggi dalam 52 minggu terakhir
DKK 556,00
Harga rendah dalam 52 minggu terakhir
DKK 233,50
Saham beredar
71,61 jt
Jumlah karyawan
578
Artikel berita
Dari sumber web dan partner berita
Investing.com Indonesia
·
2 hari yang lalu
Saham Zealand Pharma turun 3% meski hasil uji obat obesitas positif
TipRanks
·
3 hari yang lalu
Zealand Pharma Advances Petrelintide Into Phase III, Raising Its Profile in the Obesity Drug Race
TipRanks
·
3 hari yang lalu
Petrelintide Phase III Trial Puts Zealand Pharma in the Obesity–Heart Disease Spotlight
TipRanks
·
4 minggu yang lalu
Petrelintide Phase III Trial Puts Zealand Pharma in the Weight-Loss Spotlight
Profil
Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. In 2018, they opened a subsidiary in the US. Zealand Pharma forms part of the Danish-Swedish life science cluster Medicon Valley. Wikipedia
Tentang Zealand Pharma A/S